CVS removes popular cold medicines due to recent FDA findings.
CVS Removes Ineffective Decongestants from Shelves
CVS is taking action to improve customer health by removing certain decongestant products from its shelves. This decision comes after a Food and Drug Administration (FDA) advisory panel declared that these products are ineffective. CVS will no longer sell products that solely rely on phenylephrine as the active ingredient, including Sudafed PE. However, the store will continue to offer a wide range of other cough and cold products to meet consumer needs.
While some products containing phenylephrine will remain on the shelves, CVS is committed to providing effective solutions for its customers. The FDA panel’s recommendation is based on the fact that phenylephrine has been found to be less effective than other ingredients in treating congestion.
CVS’s decision to remove these decongestants aligns with its dedication to customer health and safety. Other pharmacies, such as Rite Aid, have not yet followed suit.
HEALTH ALERT: #CVS is pulling some cough and cold medications from the shelves – in the wake of a #FDA warning saying they simply aren’t effective. https://t.co/v4uiXBd1jE
— News12LI (@News12LI) October 20, 2023
The Consumer Healthcare Products Association (CHPA) acknowledges the FDA panel’s opinion but emphasizes that phenylephrine remains a Category 1 over-the-counter (OTC) ingredient recognized as safe and effective until the FDA makes a final determination. The CHPA is closely monitoring the FDA’s review of phenylephrine’s regulatory status.
According to the Wall Street Journal, the FDA panel has deemed phenylephrine safe but not effective. This ingredient has been in use since 1938, but its effectiveness has been a subject of debate for years.
The popular decongestant phenylephrine is not effective, an FDA panel found. Here’s what to use instead.
— Scientific American (@sciam) October 20, 2023
The FDA’s determination that phenylephrine is ineffective could lead to a ban on products containing this ingredient. However, the process for implementing such a ban is complex and involves drafting an order and allowing for a public comment period. Therefore, it may take months or even years before a final decision is reached.
Should all stores pull the medications?
The FDA’s findings have sparked a debate on whether all stores should remove medications containing phenylephrine from their shelves. The Western Journal conducted a poll to gather public opinion on this matter. As of now, 60% of respondents voted in favor of pulling the medications, while 40% voted against it.
A Note from Our Founder:
Every morning, we at The Western Journal wake up and pursue our mission of giving you the important information you need about what’s happening in America.
We can’t do that without your help.
America has been on the receiving end of false narratives. The purpose of these false narratives is to make you feel powerless. The Western Journal empowers you by breaking these false narratives.
But I wouldn’t be honest with you today if I didn’t let you know that the future of The Western Journal is in jeopardy without your help.
Silicon Valley and the Big Tech tyrants have done everything they can to put The Western Journal out of business. Our faithful donors and subscribers have kept us going.
If you’ve never chosen to donate, let me be honest: We need your help today.
Please don’t wait one minute. Donate right now – our situation in America is dire. Our country hangs by a thread, and The Western Journal stands for truth in this difficult time.
Please stand with us by donating today.
Floyd G. Brown
Founder of The Western Journal
The post CVS Takes Top Cold Medicines Off the Shelves After New FDA Study appeared first on The Western Journal.
What steps can The Western Journal take to continue providing reliable news and analysis
Western Journal is uncertain. As a reader, you likely understand the importance of independent news sources. We want to continue to provide you with reliable news and analysis, but we need your support to do so. If you can, please consider making a donation to The Western Journal. Your contribution will help us to continue our mission and ensure that you have access to the information you need.
Thank you for being a loyal reader. We appreciate your support.
Conclusion
CVS’s decision to remove ineffective decongestants from its shelves is a commendable step toward prioritizing customer health and safety. While other pharmacies have not yet followed suit, the FDA’s determination may push for a ban on products containing phenylephrine. It remains to be seen how the situation will evolve, but for now, consumers can rely on CVS for effective cough and cold products that meet their needs.
Additionally, the debate on whether all stores should remove these medications continues, with opinions divided. The Western Journal’s poll shows that a majority of respondents are in favor of pulling the medications, but further discussions and research are needed to reach a conclusive decision.
In the meantime, it is important for individuals to stay informed about the latest developments and consult healthcare professionals for guidance on effective decongestant options. Ensuring the well-being of customers should always remain a top priority for stores and pharmacists alike.
" Conservative News Daily does not always share or support the views and opinions expressed here; they are just those of the writer."
*As an Amazon Associate I earn from qualifying purchases
